170
Participants
Start Date
December 16, 2021
Primary Completion Date
August 2, 2023
Study Completion Date
August 2, 2023
AZD8630
Participants will receive Inhaled or IV doses of AZD8630 as per the arm they are assigned.
Placebo
Participants will receive Inhaled or IV doses of placebo as per the arm they are assigned.
Research Site, Berlin
Research Site, White Marsh
Research Site, Großhansdorf
Research Site, Lübeck
Research Site, Raleigh
Research Site, Homestead
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Magdeburg
Research Site, Toledo
Research Site, Ann Arbor
Research Site, Frankfurt
Research Site, Wiesbaden
Research Site, El Paso
Research Site, Boise
Research Site, Tempe
Research Site, Glendale
Research Site, Bakersfield
Research Site, San Jose
Research Site, Portland
Research Site, North Dartmouth
Research Site, Bradford
Research Site, London
Research Site, London
Research Site, Manchester
Research Site, Portsmouth
Lead Sponsor
AstraZeneca
INDUSTRY